LYRA (Lyra Therapeutics Inc) Company Cash on Hand

Graphic logo of lyratherapeutics.com (LYRA)

Drug development for ENT organs is independent of macroeconomics, as business value is determined by patents and the stage of clinical trials. This cash position chart illustrates liquidity dynamics, where the indicator value reaches 0.00. While a team of top-tier scientists is motivated by competitive compensation, Lyra Therapeutics, Inc. (LYRA) is currently burning through reserves and cutting costs due to clinical failures.

LYRA - Lyra Therapeutics Inc. Company Cash Balance over the range 07/04/2022 - 03/28/2026

Financial and market metric breakdowns for Lyra Therapeutics (LYRA)

- current price and projected stock value:
Comprehensive company analysis:LYRA Lyra Therapeutics, Inc
Signature product of lyratherapeutics.com

This metric measures the volume of highly liquid assets, allowing for an assessment of financial stability and the risk of cash flow gaps outside the scope of quarterly reporting. By analyzing the history of cash volume changes, an investor can compare the burn rate with the costs of final-stage clinical trials for nasal systems and the expenses associated with protecting the intellectual property of Lyra Therapeutics, Inc. (LYRA).

Competitor analysis for Lyra Therapeutics, Inc.

Company Cash Funds Haleon (HLN)|Company Cash Volume Kenvue Inc. (KVUE)|Company Cash Volume VRNA (veronapharma.com)|Company Cash Balance MENS|LGND: Company Cash on Hand|Company Cash Balance AMRX (Amneal Corp)|PRGO (Perrigo Company plc) - Company Cash on Hand|Alvotech - Company Cash Balance|Company Cash on Hand LQDA|Galapagos Genomics (GLPG) - Company Liquid Assets|Company Cash Volume ANIP|Company Cash on Hand Afrezza MNKD|Company Cash Funds Amphastar AMPH|Company Liquid Assets Pacira BioSciences (PCRX)|ARS Corp - Company Cash Volume|TBPH: Company Cash Funds|AQST: Company Cash Volume|SCPH - Company Liquid Assets|TECX (Tectonic) - Company Cash Volume|Company Cash Reserve Tonix Pharmaceuticals Holding Corp. TNXP|Company Cash Funds SXT Pharmaceuticals (SXTC)|Company Cash Volume Eupraxia Pharmaceuticals Inc. (EPRX)|Company Cash Funds BioHarvest Sciences BHST|EXOZ (Invizyne) - Company Total Cash Volume|ORMP: Company Cash on Hand|ENTX (Entera Bio Ltd) - Company Cash and Cash Equivalents|HYFT: Company Cash Volume|Company Cash on Hand ABVC BioPharma Inc.|CPIX (cumberlandpharma.com) - Company Cash Volume|Company Cash Funds QNTM|Company Cash Volume FGEN|Company Cash on Hand Telomir Pharmaceuticals TELO|Company Cash Volume RANI (ranitherapeutics.com)|SNYR (Synergy CHC Corporation) - Company Total Cash Volume|RLYB - Company Cash Funds|LEXX (Lexaria Bioscience Corp.) - Company Cash and Cash Equivalents|pulmatrix.com (PULM) - Company Cash Funds|PTHL (Pheton) - Company Cash Funds|Company Cash Funds Aptorum|Impact BioMedical Inc - Company Total Cash Volume|Company Cash Volume TNFA|YCBD - Company Cash Reserve|PainReform Ltd. - Company Cash on Hand|CYTO (Auris Medical) - Company Total Cash Volume|LIPO - Company Cash Funds|Company Cash Balance OPTN (OptiNose)|PIRS: Company Cash Volume|Procaps Group S.A. (PROC) - Company Cash Volume|PTPI (Petros Pharma) - Company Cash Volume|QLI: Company Cash Balance|Company Cash Volume SLRN|TFFP (TFF Pharmaceuticals Inc.) - Company Cash Balance